Treatment Satisfaction with Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency: a Pooled Analysis of Six Hizentra® Studies

PURPOSE: Primary immunodeficiency diseases (PIDDs) are a heterogenous group of disorders characterized by intrinsic impairment in the immune system. Most patients with PIDD require life-long immunoglobulin G replacement therapy, which has been shown to reduce the rate of infections and, related hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallick, Rajiv, Jolles, Stephen, Kanegane, Hirokazu, Agbor-Tarh, Dominique, Rojavin, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292975/
https://www.ncbi.nlm.nih.gov/pubmed/30465179
http://dx.doi.org/10.1007/s10875-018-0562-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292975/
https://www.ncbi.nlm.nih.gov/pubmed/30465179
http://dx.doi.org/10.1007/s10875-018-0562-3

Ejemplares similares